Gender-specific protective effect of hemoglobin on arsenic-induced skin lesions

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 902-907

  Breton, Carrie V ^a   Houseman, E Andres ^a   Kile, Molly L ^a   Quamruzzaman, Quazi ^b   Rahman, Mahmuder ^b   Mahiuddin, Golam ^b   Christian, David C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Dhaka Community Hospital   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HEMOGLOBIN;

ADULT; ARSENIC POISONING; ARTICLE; BANGLADESH; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENDER BIAS; HOUSEKEEPING GENE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN DEFECT;

ARSENIC; ARSENIC POISONING; BANGLADESH; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HEMOGLOBINS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; POLYMERASE CHAIN REACTION; RISK FACTORS; SKIN NEOPLASMS; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 33744719741     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0859     Document Type: Article

References (47)

1. Alam MG, Allinson G, Stagnitti F, Tanaka A, Westbrooke M. Arsenic contamination in Bangladesh groundwater: a major environmental and social disaster. Int J Environ Health Res 2002;12:235-53.
2. Rahman M. The Bangladesh arsenic catastrophe: clinical manifestations. Trop Doct 2003;33:42-4.
3. Szymanska-Chabowska A, Antonowicz-Juchniewicz J, Andrzejak R. Some aspects of arsenic toxicity and carcinogenicity in living organism with special regard to its influence on cardiovascular system, blood and bone marrow. Int J Occup Med Environ Health 2002;15:101-16.
4. Tchounwou PB, Patlolla AK, Centeno JA. Carcinogenic and systemic health effects associated with arsenic exposure-a critical review. Toxicol Pathol 2003;1:575-88.
5. Winski SL, Carter DE. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J Toxicol Environ Health 1995;46:379-97.
6. Lu M, Wang H, Li XF, et al. Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem Res Toxicol 2004;17:1733-42.
7. Delnomdedieu M, Styblo M, Thomas DJ. Time dependence of accumulation and binding of inorganic and organic arsenic species in rabbit erythrocytes. Chem Biol Interact 1995;98:69-83.
8. Delnomdedieu M, Basti MM, Styblo M, Otvos JD, Thomas DJ. Complexation of arsenic species in rabbit erythrocytes. Chem Res Toxicol 1994;7:621-7.
9. Kannan GM, Tripathi N, Dube SN, Gupta M, Flora SJ. Toxic effects of arsenic (III) on some hematopoietic and central nervous system variables in rats and guinea pigs. J Toxicol Clin Toxicol 2001;39:675-82.
10. Flora SJ, Bhadauria S, Pant SC, Dhaked RK. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life Sci 2005;77:2324-37.
11. Hatlelid KM, Brailsford C, Carter DE. Reactions of arsine with hemoglobin. J Toxicol Environ Health 1996;47:145-57.
12. Winski SL, Barber DS, Rael LT, Carter DE. Sequence of toxic events in arsine-induced hemolysis in vitro: implications for the mechanism of toxicity in human erythrocytes. Fundam Appl Toxicol 1997;38:123-8.
13. Garcia-Uribe A, Kehtarnavaz N, Marquez G, et al. Skin cancer detection by spectroscopic oblique-incidence reflectometry: classification and physiological origins. Appl Opt 2004;43:2643-50.
14. Hernandez-Zavala A, Del Razo LM, Garcia-Vargas GG, et al. Altered activity of heme biosynthesis pathway enzymes in individuals chronically exposed to arsenic in Mexico. Arch Toxicol 1999;73:90-5.
15. WHO/UNICEF/UNU. Indicators and strategies for iron deficiency and anaemia programmes. Report of consultation, Geneva, 1993 Dec 6-10. Geneva: WHO; 1997.
16. Khusun H, Yip R, Schultink W, Dillon DH. World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. J Nutr 1999;129:1669-74.
17. Ahmed F. Anaemia in Bangladesh: a review of prevalence and aetiology. Public Health Nutr 2000;3:385-93.
18. Chiou HY, Hsueh YM, Hsieh LL, et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 1997;386:197-207.
19. Strange RC, Lear JT, Fryer AA. Polymorphism in glutathione S-transferase loci as a risk factor for common cancers. Arch Toxicol Suppl 1998;20:419-28.
20. Kile M, Houseman E, Rodrigues E, et al. Toenail arsenic concentrations, GSTT gene polymorphisms, and arsenic exposure from drinking water. Cancer Epidemiol Biomarkers Prev 2005;14:2419-26.
21. Kinniburgh DG, Smedley PL. Arsenic contamination of groundwater in Bangladesh. Vol. 1. Summary, British Geological Survey Report WC/00/19. British Geological Survey and Department of Public Health and Engineering; 2001.
22. McCarty KMHE, Quamruzzaman Q, Rahman M, et al. The impact of diet and betel nut use on skin lesions associated with drinking water arsenic in Pabna, Bangladesh. Environ Health Perspect 2005. doi:10.1289/ehp.7916. Epub 2005 Sep 29.
23. Kinniburgh D, Kosmus W. Arsenic contamination in groundwater: some analytical consideration. Talanta 2002;58:165-80.
24. Barduagni P, Ahmed AS, Curtale F, Raafat M, Soliman L. Performance of Sahli and colour scale methods in diagnosing anaemia among school children in low prevalence areas. Trop Med Int Health 2003;8:615-8.
25. Chen KL, Amarasiriwardena CJ, Christiani DC. Determination of total arsenic concentrations in nails by inductively coupled plasma mass spectrometry. Biol Trace Elem Res 1999;67:109-25.
26. Hsueh YM, Huang YL, Huang CC, et al. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A 1998;54:431-44.
27. Liu G, Miller DP, Zhou W, et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res 2001;61:8718-22.
28. Ruppert D, Carroll RJ, Wand MP. Semiparametric regression. Cambridge (UK): Cambridge University Press; 2003.
29. Hastie TJ, Tibshirani RJ. Generalized additive models. New York: Chapman and Hall; 1990.
30. Thurston SW, Eisen EA, Schwartz J. Smoothing in survival models: an application to workers exposed to metalworking fluids. Epidemiology 2002;13:685-92.
31. Team RDCR. A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2005.
32. Sugiura N. Further analysis of data by Akaike's information criterion and finite corrections. Commun Stat Theory Methods A 1978;7:13-26.
33. Mitra SR, Mazumder DN, Basu A, et al. Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect 2004;112:1104-9.
34. Centeno JA, Mullick FG, Martinez L, et al. Pathology related to chronic arsenic exposure. Environ Health Perspect 2002;110 Suppl 5:883-6.
35. Kao YH, Yu CL, Chang LW, Yu HS. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem Res Toxicol 2003;16:460-8.
36. Kitchin KT, Ahmad S. Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol Lett 2003;137:3-13.
37. Fujino Y, Guo X, Liu J, et al. Chronic arsenic exposure and urinary 8-Hydroxy-2′-deoxyguanosine in an arsenic-affected area in Inner Mongolia, China. J Expo Anal Environ Epidemiol 2005;15:147-52.
38. Matsui M, Nishigori C, Toyokuni S, et al. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2′- deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol 1999;113:26-31.
39. Pi J, Yamauchi H, Kumagai Y, et al. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect 2002;110:331-6.
40. James R. The functional significance of low body mass index (BMI). Proceedings of an IDECG workshop. Rome, Italy, 4-6 November 1992. Eur J Clin Nutr 1994;48 Suppl 3:81-202.
41. Rahman MM, Chowdhury UK, Mukherjee SC, et al. Chronic arsenic toxicity in Bangladesh and West Bengal, India-a review and commentary. J Toxicol Clin Toxicol 2001;39:683-700.
42. Verret WJ, Chen Y, Ahmed A, et al. A randomized, double-blind placebo-controlled trial evaluating the effects of vitamin E and selenium on arsenic-induced skin lesions in Bangladesh. J Occup Environ Med 2005;47:1026-35.
43. Cheng HY, Li P, David M, et al. Arsenic inhibition of the JAK-STAT pathway. Oncogene 2004;23:3603-12.
44. Chiou JM, Wang SL, Chen CJ, et al. Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int J Epidemiol 2005;34:936-43.
45. Yu HS, Lee CH, Chen GS. Peripheral vascular diseases resulting from chronic arsenical poisoning. J Dermatol 2002;29:123-30.
46. Rossman TG, Uddin AN, Burns FJ. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 2004;198:394-404.
47. Burns FJ, Uddin AN, Wu F, Nadas A, Rossman TG. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ Health Perspect 2004;112:599-603.